Resource utilization in patients with brain metastases managed with best supportive care, radiotherapy and/or surgical resection: A markov analysis

Oncology

Volumn 78, Issue 5-6, 2010, Pages 348-355

  Nieder, Carsten ^a,b   Norum, Jan ^b,c   Stemland, Jørn G ^a   Dalhaug, Astrid ^a  

^a NORDLAND HOSPITAL   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c NORTHERN NORWAY REGIONAL HEALTH AUTHORITY   (Norway)

Author keywords

Best supportive care; Brain metastases; Chemotherapy; Radiotherapy; Resource utilization

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EXEMESTANE; FULVESTRANT; GEMCITABINE; IRINOTECAN; LETROZOLE; NAVELBINE; PEMETREXED; PLATINUM; SUNITINIB; TAMOXIFEN; VINCRISTINE;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER CENTER; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL CARE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NURSING HOME; PALLIATIVE THERAPY; PRIORITY JOURNAL; BRAIN NEOPLASMS; COMPLICATION; FEMALE; HEALTH CARE PLANNING; HOSPITALIZATION; LENGTH OF STAY; MALE; METASTASIS; MIDDLE AGED; MORTALITY; NEOPLASM; NORWAY; PATHOLOGY; PROBABILITY; SECONDARY; SELF HELP; STATISTICS AND NUMERICAL DATA; SURVIVAL; SURVIVAL RATE; UTILIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; HEALTH RESOURCES; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MARKOV CHAINS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS; NORWAY; NURSING HOMES; SELF-HELP GROUPS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 77956077110     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320347     Document Type: Article

References (13)

1. Nieder C, Pawinski A, Haukland E, Dokmo R, Phillipi I, Dalhaug A: Estimating need for palliative external beam radiotherapy in adult cancer patients. Int J Radiat Oncol Biol Phys 2010; 76: 207-211.
2. Nieder C, Mehta MP: Prognostic indices for brain metastases: usefulness and challenges. Radiat Oncol 2009; 4: 10.
3. Lee DH, Han JY, Kim HT, et al: Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with wholebrain radiotherapy administered first: results of a randomized pilot study. Cancer 2008; 113: 143-149.
4. Nieder C, Marienhagen K, Dalhaug A, Norum J: Have changes in systemic treatment improved survival in patients with breast cancer metastatic to the brain? J Oncol 2008; 417137.
5. Samlowski WE, Majer M, Boucher KM, et al: Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery. Cancer 2008; 113: 2539-2548.
6. Kim JH, Kim HS, Kwon JH, et al: Systemic chemotherapy after cranial irradiation in patients with brain metastases from nonsmall cell lung cancer: a retrospective study. Lung Cancer 2009; 63: 405-409.
7. Nieder C, Pawinski A, Molls M: Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status? Clin Oncol (R Coll Radiol) 2010; 22: 65-69.
8. Rades D, Pluemer A, Veninga T, Hanssens P, Dunst J, Schild SE: Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases. Cancer 2007; 110: 2285-2292.
9. Rades D, Haatanen T, Schild SE, Dunst J: Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases. Cancer 2007; 110: 1345-1350.
10. Edelman MJ, Belani CP, Socinski MA, et al: Outcomes associated with brain metastases in a three-arm phase III trial of gemcitabinecontaining regimens versus paclitaxel plus carboplatin for advanced non-small cell lung cancer. J Thorac Oncol 2010; 5: 110-116.
11. Pompen M, Gok M, Novak A, et al: Direct costs associated with the disease management of patients with unresectable advanced non-small-cell lung cancer in The Netherlands. Lung Cancer 2009; 64: 110-116.
12. Pelletier EM, Shim B, Goodman S, Amonkar MM: Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis. Breast Cancer Res Treat 2008; 108: 297-305.
13. Mehta M, Noyes W, Craig B, et al: A costeffectiveness and cost-utility analysis of radiosurgery vs. resection for single-brain metastases. Int J Radiat Oncol Biol Phys 1997; 39: 445-454.